Drug safety: from development to clinical use
Ovchinnikova, E.A.; Gerasimov, V.B.
Antibiotiki i Khimioterapiia 51(6): 15-22
2006
ISSN/ISBN: 0235-2990 PMID: 17523417 Document Number: 604165
Document emailed within 1 workday
Related Documents
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62Maksimov, V.A.; Logvinov, L.A.; Danovich, V.M.; Kumachev, K.V.; Cherniatin, A.A. 2009: Clinical efficacy and safety of the drug "Likoprofit potential-formula" Urologiia 6: 56-59
Despotou, G.; Korkontzelos, I.; Matragkas, N.; Bilici, E.; Arvanitis, T.N. 2018: Structuring Clinical Decision Support Rules for Drug Safety Using Natural Language Processing Studies in Health Technology and Informatics 251: 89-92
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Lassere, M.N.D.; Johnson, K.R.; Boers, M.; Carlton, K.; Day, R.O.; de Wit, M.; Edwards, I.Ralph.; Fries, J.F.; Furst, D.E.; Kirwan, J.R.; Tugwell, P.S.; Woodworth, T.G.; Brooks, P.M. 2005: Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update Journal of Rheumatology 32(10): 2037-2041
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Reich, K.; Papp, K.A.; Griffiths, C.E.M.; Szapary, P.O.; Yeilding, N.; Wasfi, Y.; Ott, E.; Hsu, M-Chun.; Lebwohl, M.; Gordon, K.B. 2012: An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up Journal of drugs in dermatology: JDD 11(3): 300-312
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Thirstrup, S.; Heisterberg, J. 2008: Children on the drug development map. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 170(12): 1039
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Leonard, B. 1987: Drug safety and drug toxicity: the Irish situation Irish Medical Journal 80(4): 106-107
Briejer, M. 2002: Advances in cardiovascular drug development. Biomarkers, surrogates and clinical progress Idrugs: the Investigational Drugs Journal 5(12): 1131-1133
Jordan, S.C.; Choi, J.; Vo, A. 2015: Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials Process Clinical Transplants 31: 163-172
Prabhu, V.V. 2008: A comparative clinical trial evaluating efficacy and safety of fixed dose combination of nimesulide (100 mg) and racemethionine (50 mg) (namsafe) versus reference drug (nimesulide) and other NSAIDs in the treatment of osteoarthritis Journal of the Indian Medical Association 106(6): 402-404
Siegel, M.B.; Van Swearingen, A.E.D.; Anders, C.K. 2014: Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis Oncology 28(7): 579; 584-585
Cooper, J.B.; Gaba, D.M.; Liang, B.; Woods, D.; Blum, L.N. 2000: The National Patient Safety Foundation agenda for research and development in patient safety Medgenmed: Medscape General Medicine 2(3): E38
Kimbel, K.H. 1978: Drug safety through drug legislation Der Internist 19(6): 326-332
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75